C3G & Primary
IC-MPGN Deep Dive
C3G and primary IC-MPGN are rare, often misunderstood kidney diseases with clear, unmet needs; up to 50% of adults progress to end-stage kidney disease within a decade, exploring, complement dysregulation, clinical presentation, and evolving treatment options.
C3G and Primary IC-MPGN: Understanding the Disease
A powerhouse panel of nephrology, transplantation, and renal pathology experts comes together for a 360-degree exploration of C3G and primary IC-MPGN from underlying mechanisms to new strategies of disease-modifying approaches.
Early Intervention: Transforming Outcomes in C3 Glomerulopathy
When conventional therapies only mask symptoms, timing becomes critical. This case highlights the diagnostic journey and the transformative impact of early targeted complement inhibition in C3 glomerulopathy.
Real-World Evidence: Empaveli in Adolescent primary IC-MPGN
A complex adolescent primary IC-MPGN case reveals how a double pathology diagnosis and targeted therapy challenged conventional approaches and reshaped treatment strategy.
Simplify Understanding of Complement System in C3G and IC-MPGN
this video breaks down complement dysregulation in C3G and primary IC-MPGN, showing how three pathways converge at a tipping point and where targeted therapy restores balance.
Watch leading specialists tackle real-world clinical cases